A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer Participants
Clinical trial NCT03437083 · COMPLETED
Trial details
- NCT number
- NCT03437083
- Sponsor
- Eisai Korea Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-01-25
- Primary completion
- 2018-06-30
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.